Publications & Reports

HIV prevention in a time of COVID-19: A report from the HIVR4P // Virtual conference 2021.

Laher F, Richardson SI, Smith P, Sullivan P, Abrahams AG, Asowata OE, Bitangumutwenzi P, Dabee S, Dollah A, Fernandez N, Langat RK, Bose DL, Likhitwonnawut U, Mullick R, Resop RS, Sutar J, Thompson-Hall AN, Traeger MW, Tuyishime M, Wambui J, Bekker LG, Kaleebu P, McCormack S, O'Connor DH, Warren M, Torri T, Thyagarajan B
University of the Witwatersrand, Perinatal HIV Research Unit (PHRU), Soweto, Gauteng, South Africa; [email protected]

Abstract

The HIV Research for Prevention (HIVR4P) conference catalyzes knowledge-sharing on biomedical HIV prevention interventions such as HIV vaccines, antibody infusions, pre-exposure prophylaxis (PrEP) and microbicides in totality - from the molecular details and delivery formulations to the behavioral, social and structural underpinnings. HIVR4P // Virtual was held over the course of two weeks on 27-28 January and 3-4 February 2021 as the COVID-19 pandemic continued to inflict unprecedented harm globally. The HIVR4P community came together with 1,802 researchers, care providers, policy-makers, implementors and advocates from 92 countries whose expertise spanned the breadth of the HIV prevention pipeline from pre-clinical to implementation. The program included 113 oral and 266 poster presentations. This article presents a brief summary of the conference highlights. Complete abstracts, webcasts and daily rapporteur summaries may be found on the conference website (https://www.hivr4p.org/).

Link o publisher’s web site

Publication

  • Journal: AIDS Research and Human Retroviruses
  • Published: 01/01/2022
  • Volume: Epub ahead of print

Author